These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 326117)

  • 21. [Delayed platinum diamminodichloride toxicity in patients with germ tumors of the gonads].
    Germà Lluch JR; Izquierdo Font A; Barnadas Molins A; Arcusa Lanza MA; Ojeda González B
    Med Clin (Barc); 1984 Mar; 82(10):442-5. PubMed ID: 6538917
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical trials of cis-diamminedichloroplatinum (NSC-119875).
    Lippman AJ; Helson C; Helson L; Krakoff IH
    Cancer Chemother Rep; 1973 Apr; 57(2):191-200. PubMed ID: 4126381
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cis-diammino-dichloro-platinum therapy of cancers; phase II therapeutic trial].
    Hayat M; Bayssas M; Brulé G; Cappelaere P; Cattan A; Chauvergne J; Clavel B; Gouveia J; Guerrin J; Pommatau E; Muggia F; Mathé G
    Nouv Presse Med; 1979 Mar; 8(15):1231-4. PubMed ID: 375187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carboplatin versus cisplatin in solid tumors: an analysis of the literature.
    Lokich J; Anderson N
    Ann Oncol; 1998 Jan; 9(1):13-21. PubMed ID: 9541678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-agent cis-platinum therapy for advanced ovarian cancer.
    Gershenson DM; Wharton JT; Herson J; Edwards CL; Rutledge FN
    Obstet Gynecol; 1981 Oct; 58(4):487-96. PubMed ID: 7024883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of prolonged intravenous infusions of cisplatin in patients with malignant neoplasms].
    Tiuliadin SA
    Vopr Onkol; 1983; 29(12):40-4. PubMed ID: 6582683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical evaluation of toxic effects of cis-diamminedichloroplatinum (NSC-119875)--phase I clinical study.
    Talley RW; O'Bryan RM; Gutterman JU; Brownlee RW; McCredie KB
    Cancer Chemother Rep; 1973; 57(4):465-71. PubMed ID: 4762440
    [No Abstract]   [Full Text] [Related]  

  • 28. Review of the current clinical status of platinum coordination complexes in cancer chemotherapy.
    Gottlieb JA; Drewinko B
    Cancer Chemother Rep; 1975; 59(3):621-8. PubMed ID: 1106840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diaminodichloroplatinum: a phase I study showing responses in testicular and other tumors.
    Higby DJ; Wallace HJ; Albert DJ; Holland JF
    Cancer; 1974 May; 33(5):1219-5. PubMed ID: 4856724
    [No Abstract]   [Full Text] [Related]  

  • 30. [Phase II study of cis-diamminedichloroplatinum (II) in genitourinary cancer].
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):433-42. PubMed ID: 6764107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The chemotherapy of urologic neoplasms].
    Cavalli F
    Helv Chir Acta; 1978 Jul; 45(3):223-32. PubMed ID: 359509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin: impact of a new anticancer agent on current therapeutic strategies.
    Rozencweig M; Abele R; von Hoff DD; Muggia FM
    Anticancer Res; 1981; 1(4):199-204. PubMed ID: 7049048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic evaluation of cisplatin in children with malignant solid tumors: a phase II study.
    Pratt CB; Hayes A; Green AA; Evans WE; Senzer N; Howarth CB; Ransom JL; Crom W
    Cancer Treat Rep; 1981; 65(11-12):1021-6. PubMed ID: 7197583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phase II study of CIS-diamminedichloroplatinum (II) by collaborative study].
    Kato T
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):694-701. PubMed ID: 6892198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum(II) in head and neck cancer patients.
    Forastiere AA; Belliveau JF; Goren MP; Vogel WC; Posner MR; O'Leary GP
    Cancer Res; 1988 Jul; 48(13):3869-74. PubMed ID: 3378222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Phase 2 study with cis-dichlorodiaminoplatinum (II) in advanced solid tumors].
    Francesconi M; Mörz R; Rainer H; Moser K
    Onkologie; 1980 Dec; 3(6):301-6. PubMed ID: 7012728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced male non-seminomatous germ-cell tumours. Combination chemotherapy with cis-platinum, vinblastine and bleomycin.
    Woods RL; Fox RM; Tattersall MH
    Med J Aust; 1979 Dec; 2(12):630-2. PubMed ID: 94148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The iodine 131-hippurate clearance for the determination of the nephrotoxic effect of cis-dichlorodiamino-platin (II) (cis-platin, cis-DDP)].
    Wendt TG; Hartenstein R; Büll U; Schlechtweg K; Moser EA
    Klin Wochenschr; 1983 Jun; 61(11):561-6. PubMed ID: 6683771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose cis-diamminedichloro-platinum therapy in patients with advanced breast cancer: pharmacokinetics, toxicity, and therapeutic efficacy.
    Ostrow S; Egorin M; Aisner J; Bachur N; Wiernik PH
    Cancer Clin Trials; 1980; 3(1):23-7. PubMed ID: 7190082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.